Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-399-7 | CAS number: 140-11-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
One skin sensitisation study is available. Hartley guinea pigs were used as the test species. The study was conducted using the Guinea Pig maximisation test using the Magnusson-Kligmann method.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 June 1985 - 9 August 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- no guideline followed
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Principles of method if other than guideline:
- Twenty animals per test group were injected intradermally on day 0 with different concentrations or the test material in physiological saline. Each animal also received two intradermal injections of 50% v/v Freund's complete adjuvant (FCA) in distilled water and two injections of the test or control material in the FCA formulation. On day 7 or 8, the test animals in the groups received different concentrations of the test material in petrolatum topically under elastoplast bandage wrappings for 48 hours. On day 19 or 21, the respective induced test animals were challenged with the three concentrations of the test material in petrolatum plus undiluted petrolatum topically under Elastoplast bandage wrappings for 24 hours. On the day after removal of the topical application, the sites were depilated. Later that day and again the next day, the sites were graded for erythema responses (24 and 48 hour responses).
- GLP compliance:
- not specified
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- An older guinea pig maximisation test is available that is acceptable for classification purposes; further testing by the LLNA method is not considered necessary
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Benzyl Acetate
- Physical state: Liquid with strong odour
- Storage condition of test material: refrigeration in covered amber glass bottles - Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Lab Animal Supply Company
- Age at study initiation: not stated
- Weight at study initiation: 300 - 400 g
- Housing: singly in wire mesh suspension cages
- Diet (e.g. ad libitum): Purina Guinea Pig Chow ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Photoperiod (hrs dark / hrs light): 12 hour light/12 hour dark cycle
IN-LIFE DATES: From: 9 July 1985 To: 2 August 1985 - Route:
- intradermal and epicutaneous
- Vehicle:
- petrolatum
- Concentration / amount:
- Primary irritation: 100, 50, 25, 10, 5, 2.5, 1.25 and 0.625% v/v
Induction - intradermal:
- Site 1: 50% v/v FCA in distilled water (all groups)
- Site 2: 10% test substance in saline (tes group), undiluted saline (control group)
- Site 3: 10% test substacne in FCA (test group), 50% FCA in saline (control group
Induction - Topical: 30% v/v test substance in petrolatum to all sites - Route:
- epicutaneous, semiocclusive
- Vehicle:
- petrolatum
- Concentration / amount:
- Primary irritation: 100, 50, 25, 10, 5, 2.5, 1.25 and 0.625% v/v
Induction - intradermal:
- Site 1: 50% v/v FCA in distilled water (all groups)
- Site 2: 10% test substance in saline (tes group), undiluted saline (control group)
- Site 3: 10% test substacne in FCA (test group), 50% FCA in saline (control group
Induction - Topical: 30% v/v test substance in petrolatum to all sites - No. of animals per dose:
- 20
- Details on study design:
- RANGE FINDING TESTS:
Primary irritation
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
- Exposure period: -
- Test groups:
Induction - intradermal:
Site 1: 50% v/v FCA in distilled water (all groups)
Site 2: 10% test substance in saline (tes group)
Site 3: 10% test substacne in FCA (test group)
Induction - Topical: 30% v/v test substance in petrolatum to all sites
- Control group: 1
Induction - intradermal:
Site 1: 50% v/v FCA in distilled water (all groups)
Site 2: undiluted saline (control group)
Site 3: 50% FCA in saline (control group)
Induction - Topical: Undiluted petrolatum to all sites
- Site: 3 sites each side of the midline
- Frequency of applications: Once for each type of induction
- Duration: One intradermal, the other topical for 48 hours
- Concentrations: intradermal 30%, topical 10%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 19 or 21
- Exposure period: 24 hours
- Test groups: test substance
- Control group: test substance
- Site: left flank
- Concentrations: the maximum non-irritating concentration and two lower concentrations
- Evaluation (hr after challenge): 4-8 hours after patch removal (24-hour reading) and the next day (28-hour reading) - Challenge controls:
- 12 animals, male/female, Maximum non-irritating concentration
- Positive control substance(s):
- no
- Positive control results:
- N/A
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 1% v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No data.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 3% v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No data.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no data
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10% v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no data.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10% v/v
- No. with + reactions:
- 3
- Total no. in group:
- 12
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 10% v/v. No with. + reactions: 3.0. Total no. in groups: 12.0. Clinical observations: No data.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 8
- Total no. in group:
- 20
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: Undiluted vehicle. Dose level: 0. No with. + reactions: 8.0. Total no. in groups: 20.0. Clinical observations: No data.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1% v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No data.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 3% v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No data.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10%v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10%v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No data.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10% v/v
- No. with + reactions:
- 3
- Total no. in group:
- 12
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 10% v/v. No with. + reactions: 3.0. Total no. in groups: 12.0. Clinical observations: No data.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 8
- Total no. in group:
- 20
- Clinical observations:
- No data
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: Undiluted vehicle. Dose level: 0. No with. + reactions: 8.0. Total no. in groups: 20.0. Clinical observations: No data.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The responses to the test substance were rated as weak. Benzyl acetate is not considered to be sensitising. According to Regulation (EC) No. 1272/2008, no classification is warranted.
- Executive summary:
Twenty animals per test group were injected intradermally on day 0 with different concentrations or the test material in physiological saline. Each animal also received two intradermal injections of 50% v/v Freund's complete adjuvant (FCA) in distilled water and two injections of the test or control material in the FCA formulation. On day 7 or 8, the test animals in the groups received different concentrations of the test material in petrolatum topically under elastoplast bandage wrappings for 48 hours. On day 19 or 21, the respective induced test animals were challenged with the three concentrations of the test material in petrolatum plus undiluted petrolatum topically under Elastoplast bandage wrappings for 24 hours. On the day after removal of the topical application, the sites were depilated. Later that day and again the next day, the sites were graded for erythema responses (24 and 48 hour responses).
According to Regulation (EC) No. 1272/2008, no classification is warranted.
Reference
Group |
Concentration |
Number of responders / Number treated |
Mean severity (24 hours) |
Mean severity (48 hours) |
Class of response |
Test |
10 |
0/20 |
0.5 |
0.5 |
Weak |
Test |
3 |
0/20 |
0.5 |
0.6 |
Weak |
Test |
1 |
0/20 |
0.5 |
0.6 |
Weak |
Control |
10 |
3/12 |
0.5 |
0.5 |
Mild |
Control (vehicle) |
Undiluted |
8/20 |
0.5 |
0.8 |
Moderate |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a study conducted by Kreuzmann (1985), the test substance, benzyl acetate was examined for its ability to cause sensitisation. Twenty Hartley guinea pigs per test group were injected intradermally on day 0 with different concentrations or the test material in physiological saline. Each animal also receeved two intradermal injections of 50% v/v Freund's complete adjuvant (FCA) in distilled water and two injections of the test or control material in the FCA formulation. On day 7 or 8, the test animals in the groups recieved different concentrations of the test material in petrolatum topically under elastoplast bandage wrappings for 48 hours. On day 19 or 21, induced test animals were challenged with the three concentrations of the test material in petrolatum plus undiluted petrolatum topically under Elastoplast bandage wrappings for 24 hours. On the day after removal of the topical application, the sites were depilated. Later that day and again the next day, the sites were graded for erythema responses (24 and 48 hour responses).
According to Regulation (EC) No. 1272/2008, no classification is warranted.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Skin Sensitisation:
Based on the results of the available study, the test susbtance does not require classification according to Regulation EC No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.